Alopecia areata
☆ Yn 'e 2022 Stiftung Warentest-resultaten út Dútslân wie de konsuminttefredenheid mei ModelDerm mar wat leger dan mei betelle telemedisynkonsultaasjes.
Alopecia areata wurdt sjoen op 'e rêch fan' e hoofdhuid. Yn typyske gefallen ferskynt it ynienen mei in folslein glêd oerflak en in grutte fan 2-3 sm.
References
Alopecia areata is in betingst wêryn jo ymmúnsysteem jo hierfollikels oanfalt, wat liedt ta tydlik hierferlies sûnder littekens. It kin ferskine as plakjes fan hierferlies of beynfloedzje jo heule hoofdhuid of lichem, en beynfloedet sawat 2% fan minsken op ien of oare stadium yn har libben. De wichtichste skuldige liket in ôfbraak te wêzen yn 'e natuerlike beskerming om' e hierfollikels.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is in betingst wêryn it ymmúnsysteem hierfollikels oanfalt, wêrtroch hier ferlies op 'e hoofdhuid en oare hierige dielen fan it lichem feroarsaket. It beynfloedet sawat 2% fan minsken wrâldwiid. Hoewol it op elke leeftyd kin foarkomme, komt it faker foar by bern dan by folwoeksenen (1. 92% vs. 1. 47%) . Wyfkes, benammen dy boppe de 50, meie it mear ûnderfine as manlju. Injeksje fan kortikosteroïden direkt yn 'e troffen gebieten hat bettere resultaten sjen litten as se topikaal tapasse.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata wurdt leaud in autoimmune sykte te wêzen dy't ferbân hâldt mei it ymmúnsysteem fan 'e hierfollikels. It ûnderlizzende meganisme omfettet it mislearjen fan it lichem om syn eigen sellen te erkennen, mei dêropfolgjende ymmún-bemiddele ferneatiging fan 'e hierfollikel.
○ Behanneling ― OTC Drugs
Guon minsken mei milde alopecia areata herstelle binnen in jier sûnder behanneling. De measte minsken belibje lykwols werhellingen op willekeurige plakken op 'e hoofdhuid.
#Hydrocortisone cream
○ Behanneling
Intralesionale steroide ynjeksjes binne de meast effektive behanneling. Immunoterapy kin besocht wurde as grutte gebieten fan 'e hoofdhuid beynfloede binne.
#Triamcinolone intralesional injection
#DPCP immunotherapy